Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Anti-TNF
Crohn’s disease
Upper gastrointestinal tract
Eligibility
Alkylating agents
Vedolizumab
CARCINOGENESIS
Colonic epithelial primary cells
Eradication
Colorectal cancer
Dysbiosis
PCR
Microbiote
Patients experience
Contraindication
Disability
Primary sclerosing cholangitis
Immune cells
Consensus
IL23
Cancer
MICROBIOTA
Fecal microbiota
HIV
MORTALITY
Colon
Gene expression
Ustekinumab
Neoadjuvant chemotherapy
Gènes
Clinical trial
Helicobacter pylori
Thérapie ciblée
MALT
Safety
Clinical guidelines
Therapeutics
IL12
Drug
Rituximab plus chlorambucil
Inclusion
Disease Progression
Ulcerative colitis
Stricture
Small molecules
Crohn's disease
Gene methylation
Patient-reported outcome
Venous thromboembolism
MARKER
Tuberculosis
Bacteria
DNA methylation
T1118 translocation
COLON-CANCER
Intestinal crypts
Inhibitor
Colorectal cancer Colibactin and lipids
Heart disease risk factors
Epigenetics
Colon cancer
Biologics
Rituximab
Tailored therapy
Over 80s
Résistance
DNA METHYLATION
Colectomy
Screening
Immunosuppressant
Anti-TNF agents
Cell adhesion
Epigénétiques
Maintenance therapy
Parvimonas micra
Microbiota
Disease progression
Surgery
RISK
Acceptability
Inflammatory bowel disease
Bactéries
Resistance
Algorithm
Méthylation
Methylation
Inflammatory Bowel Diseases
Original Article Clinical
18 FDG-PET/CT
Dysbiose
Effectiveness
Cost effectiveness
Biomarker
Inflammatory bowel diseases
IBD
Survival
Monitoring
Kidney diseases
Genes
Endoscopic treatment
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Lucas Guillo, Mathieu Uzzan, Laurent Beaugerie, Jean-Marc Gornet, Aurélien Amiot, et al.. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study. Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.787-797.e2. ⟨10.1016/j.cgh.2020.12.023⟩. ⟨hal-04168380⟩
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩
-
Maria Nachury, Yoram Bouhnik, Mélanie Serrero, Jerome Filippi, Xavier Roblin, et al.. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩. ⟨hal-03038260⟩
-
Julien Tap, Aurélien Amiot, Véronique Jarrousse, Sandra Guilmeau, Jeanne Tran Vannhieu, et al.. Early Phenotypical Changes Induced By Transfer Of Human Fecal Microbiota from Colorectal Cancer Patients To Germ-Free Mice. International Journal of Cancer and Oncology, 2017, 4 (1), pp. 1-11. ⟨10.15436/2377-0902.16.1128⟩. ⟨hal-03825702⟩
-
Nicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, Anne Bourrier, Xavier Treton, et al.. Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.609 - 618. ⟨10.1016/j.clinre.2019.11.008⟩. ⟨hal-03492351⟩